Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) rose 50% during trading on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. Approximately 1,942,446 shares were traded during trading, an increase of 1,795% from the average daily volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Price Performance
The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The stock has a market capitalization of C$13.95 million, a PE ratio of -10.00 and a beta of 0.32. The stock’s 50-day moving average is C$0.07 and its 200 day moving average is C$0.06.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- What Does a Stock Split Mean?
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- What Investors Need to Know to Beat the Market
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- How to Invest in Blue Chip Stocks
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
